Aripiprazole Prescribing Patterns and Side Effects in Elderly Psychiatric Inpatients

2009 ◽  
Vol 15 (2) ◽  
pp. 150-153 ◽  
Author(s):  
Kim C. Coley ◽  
Tina M. Scipio ◽  
Christine Ruby ◽  
Eric J. Lenze ◽  
Tanya J. Fabian
1993 ◽  
Vol 5 (1) ◽  
pp. 7-11 ◽  
Author(s):  
John Huszonek ◽  
Mantosh Dewan ◽  
Marvin Koss ◽  
William Hardoby ◽  
Abbas Ispahani

2018 ◽  
Vol 36 (30_suppl) ◽  
pp. 53-53
Author(s):  
Jordan Stosky ◽  
Jackson S.Y. Wu ◽  
Alysa M. Fairchild ◽  
Marc Kerba

53 Background: Radiotherapy (RT) is a resource intensive cancer treatment. Benefits may take weeks to realize, whereas side effects are more immediate. RT is commonly delivered with palliative intent often near the end of life (EOL). In patients with limited life expectancy, single fractions (sf) may substitute for multi-fraction (mf) treatments. Objectives were to document RT courses delivered to patients with cancer at EOL, with the goal of informing treatment practices, developing a clinical decision-making tool and reducing potentially futile treatment and side effects for patients. Methods: Cancer Registry data was examined with ethics approval. Patient and prospective treatment data were collected and analyzed to determine the number of RT courses starting within 90 days of death (EOL) among those with cancer diagnoses who died between January 1, 2016, and July 31, 2017. Data was stratified by demographics, disease factors, RT center and prescription factors. Results are reported in aggregate and explored using tests of association (Stata 11.1). Results: Among 1874 patients who died, 2448 RT courses were identified across 4 RT centers. Of those prescribed RT at the EOL, there were 442 sf courses 100% completed, 1267 2-5 fraction courses 90% completed, 552 6-10 fraction courses 77% completed, and 187 11+ fraction courses 57% completed. Among patients prescribed RT 14 days prior to death, 24% had been prescribed a sf of RT compared to 18% of those within 90 days of death (Chi2 17.92, p < 0.001). Among patients prescribed RT 90 days prior to death, 25% of patients in tertiary Centre A were prescribed a sf compared to 13% of patients in tertiary Centre B (Chi2 121.90, p < 0.001). Patients were half as likely (RR = 0.47, 95% CI [0.39, 0.56], p < 0.001) to complete a mf treatment within 14 days of their death as compared to within 90 days. Patients who had a diagnosis to death interval of under a year were less likely to complete RT than those over a year (RR = 0.82, 95% CI [0.79, 0.85], p < 0.001). Conclusions: Multi-fraction RT is often not completed prior to death. Treating RT center is associated with differences in prescribing patterns. Better understanding of factors influencing RT practice patterns may lessen the proportion of potentially futile RT.


2021 ◽  
Vol 12 ◽  
Author(s):  
Alfonso Ceccherini-Nelli ◽  
Elena Bucuci ◽  
Lisa Burback ◽  
Daniel Li ◽  
Maryam Alikouzehgaran ◽  
...  

Managing violent behavior is a particularly challenging aspect of hospital psychiatric care. Available pharmacological interventions are often unsatisfactory.Aim: To assess the effectiveness and safety of daytime zopiclone add-on administration in violent and difficult-to-treat psychiatric inpatients.Methods: Chart review of inpatients treated with daytime zopiclone, between 2014 and 2018, with up to 12 weeks follow-up. Effectiveness was retrospectively assessed with the Clinical Global Impression rating scale (CGI) and the frequency and severity of aggressive incidents recorded with the Staff Observation Aggression Scale-Revised (SOAS-R).Results: Forty-five (30 male, 15 female) cases, 18–69 years age range, average (SD) baseline CGI-S score of 5.4 (1.0), and a variety of diagnoses. Sixty-nine percent showed CGI-S improvement of any degree. For patients with at least one aggressive incident within 7 days prior to initiation of zopiclone (N = 22), average (SD) SOAS-R-Severity LOCF to baseline change was −3.5 (2.7) P &lt; 0.0001. Most patients reported no side effects; 24% reported one or more side effects, and 11% discontinued zopiclone due to sedation (4), insomnia (1) or slurred speech (1). No SAEs were recorded. Zopiclone maximum daily dose correlated with CGI-S baseline-to-LOCF change (rho = −0.5, P = 0.0003). The ROC AUC of zopiclone maximum daily dose and improvement on CGI-S was 0.84 (95% CI 0.70–0.93, P &lt; 0.0001). The ROC AUC of zopiclone maximum daily dose and SOAS-R-N improvement was 0.80 (95% CI 0.58–0.92; P = 0.0008) and maximum Youden's index value was achieved at a dose of &gt;30 mg.Conclusions: Zopiclone doses &gt;30 mg daily achieved the best anti-aggressive effect.


2007 ◽  
Vol 21 (2) ◽  
pp. 153-160 ◽  
Author(s):  
Simon J. C. Davies ◽  
Martin S. Lennard ◽  
Parviz Ghahramani ◽  
Peter Pratt ◽  
Andrea Robertson ◽  
...  

Medications are commonly prescribed to psychiatric inpatients on a PRN ( pro re nata/as required) basis, allowing drugs to be administered on patient request or at nurses' discretion for psychiatric symptoms, treatment side effects or physical complaints. However, there has been no formal study of the pharmacokinetic implications of PRN prescribing. The objective of the study was to determine the prevalence of PRN drug prescription and administration, and to assess the potential for interactions involving CYP2D6 and CYP3A4 between drugs prescribed and administered to inpatients on psychiatry wards. A cross-sectional survey of prescriptions on general adult and functional elderly psychiatric wards in one city was carried out. Data were recorded from prescription charts of 323 inpatients (236 on general adult and 87 on functional elderly wards). Of 2089 prescriptions, 997 (48%) of prescriptions were on a PRN basis (most commonly benzodiazepines and other hypnotic agents, antipsychotics, analgesics and anticholinergic agents), but only 143 (14%) of these had been administered in the previous 24 hours. One fifth of patients were prescribed drug combinations interacting with CYP2D6 or CYP3A4 of potential clinical importance which included one or more drugs prescribed on a PRN basis. PRN prescribing is common among inpatients in psychiatry, and may lead to cytochrome P450 mediated interactions. Prescribers should be aware of the potential for unpredictability in plasma concentrations, side effects and efficacy which PRN prescribing may cause through these interactions, particularly in old age psychiatry and in treatment of acute psychosis.


1989 ◽  
Vol 19 (2) ◽  
pp. 221-243 ◽  
Author(s):  
Pearl S. German ◽  
Lynda C. Burton

The increase of the elderly within our population makes for increased chronic disease and, hence, greater use of sophisticated medications now available. This paper reviews current knowledge of the pharmacodynamics and pharmacokinetics among elderly users of drugs and estimates the prevalence of use of prescribed drugs. Less is known of specifics of prescribing patterns, but evidence clearly suggests the strong influence of patient/doctor communication in compliance and control of side effects. There is little hard evidence on the populations considered at high risk for inappropriate prescribing and use and for side effects. The influence of race, socioeconomic class and age are all suggested Since drugs and their uses increase daily, it is important to investigate the area of high-risk populations in order to accumulate evidence which can lead to appropriate interventions.


Author(s):  
Nehad J. Ahmed ◽  
Menshawy A. Menshawy

Objective: The aim of this study was to describe the prescribing pattern of isosorbide dinitrate in outpatient department. Methods: The study was carried out at outpatient department in Alkharj. The collected data included personal data, dosage forms of the prescribed isosorbide dinitrate, the prescribing departments and the level of the prescribers. Results: Isosorbide dinitrate was prescribed to 57 patients in the outpatient department; about 61.4% of them aged more than 59. About 80.7% of patients received isosorbide dinitrate tablets and 19.3% of them received sublingual tablets. Most of the prescriptions were prescribed by cardiology department (56.14%) followed by Internal Medicine department (26.32%). Conclusion: Isosorbide dinitrate prescribing was uncommon in the outpatient setting but it can cause several side effects and drug interactions, besides some patients are allergic to it. So the doctor should judge that the benefit to the patient is greater than the risk of side effects.


Sign in / Sign up

Export Citation Format

Share Document